Caricamento...
Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review)
A severe immune response in patients with coronavirus disease 2019 (COVID-19) can cause a potentially lethal unconstrained inflammatory cytokine storm, known as cytokine release syndrome (CRS). The present study provides an overview of the biology underlying CRS and how targeted inhibition of interl...
Salvato in:
| Pubblicato in: | Exp Ther Med |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7690237/ https://ncbi.nlm.nih.gov/pubmed/33262810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2020.9456 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|